top of page
Executive Spotlights

Moderna to buy Japan-based OriCiro Genomics for US $85M

Cambridge, MA, January 4, 2023 (Proactive Investors) -- Moderna Inc, the biotech pioneering messenger RNA (mRNA) therapeutics and vaccines, said it has struck a deal to buy Japan-based OriCiro Genomics for US$85 million to boost its manufacturing capabilities.

Read full article here.

Recent Posts

See All

Santa Clara, CA, January 17, 2023 (RTTNews) -- Shockwave Medical, Inc. (SWAV) has entered into a definitive agreement to acquire Neovasc Inc. (NVCN). Shockwave will acquire all outstanding Neovasc s

Life Science Headlines
bottom of page